Alzamend Neuro share price logo

Alzamend Neuro

NASDAQ: ALZN

$1.30

+0.02

(+1.56%)

as on

Alzamend Neuro Stock Performance

as on October 17, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $1.25
    $1.34
    downward going graph

    3.85%

    Downside

    3.08%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.84
    $2.68
    downward going graph

    35.38%

    Downside

    106.15%

    Upside

    downward going graph

Alzamend Neuro share price movements today

Previous Close
$1.28
Open
$1.29
Volume
210.8K
Market Cap
$6.2M
Day's Low - High
$1.25 - $1.34
52 Week Low - High
$0.84 - $2.68

Alzamend Neuro Historical Returns

1 Month Return
-29.35 %
3 Month Return
+ 7.44 %
1 Year Return
-41.44 %
3 Year Return
-99.54 %
5 Year Return
-99.96 %

Alzamend Neuro Stock Fundamentals & Key Indicators

Check Alzamend Neuro market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$6.2M

EPS (TTM)

-2.3

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.56

Industry PE ratio

-3.02

PEG Ratio

-0.00

EBITDA

-9.0M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-277.88%

Alzamend Neuro vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Alzamend Neuro with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$6.2M-99.96%-0.560.00%0.00%
Neutral$94.4B-32.76%-29.64-12.57%0.00%
StrongBuy$128.9B174.93%29.3786.04%0.00%
Buy$80.1B42.93%19.0184.86%0.46%

Stock Returns calculator for Alzamend Neuro Stock including INR - Dollar returns

The Alzamend Neuro stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Alzamend Neuro investment value today

Current value as on today

₹63,188

Returns

-₹36,812

(-36.81%)

Returns from Alzamend Neuro Stock

-₹41,441 (-41.44%)

Dollar Impact

₹4,630 (+4.63%)

Analyst Recommendation on Alzamend Neuro Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Alzamend Neuro. Average target price of $26

Alzamend Neuro Share Price Target

Get share price movements and forecasts by analysts on Alzamend Neuro.

What analysts predicted

95%UPSIDE

Target Price

$26

Current Price

$1.3

Analyzed by

8 Analysts

Target

$26.00

Alzamend Neuro target price $26, a slight upside of 95% compared to current price of $1.3. According to 8 analysts rating.

Indian Investors' Interest in Alzamend Neuro Stock

Search interest for Alzamend Neuro Stock has increased by 2% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:2% versus previous 30 day period

Alzamend Neuro Quarterly Profit & Loss

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
0
0
Operating Income
0
0
-1
-1
-1
-2
0
-2
-2
-3
EBITDA
0
0
-1
-1
-1
-2
0
-2
-2
-2
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
0
0
-1
-1
-1
-2
-1
-2
-2
-3
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
0
0
-1
-1
-1
-2
-1
-2
-2
-3
Net Profit Margin
-16.67%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Annual Profit & Loss

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Total Revenue
-
-
-
-
-
-
-
-
-
-
Gross Profit
-
-
-
-
-
-
-
-
-
-
Operating Income
-1
0
-5
-4
-4
-12
-14
-9
-4
-8
EBITDA
0
0
-5
-4
-4
-12
-14
-9
-4
-8
Interest Expense
-
-
-
-
0
0
0
0
0
0
Depreciation
1
0
-
-
-
0
0
0
0
0
Income Before Tax
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Alzamend Neuro Quarterly Cash Flow

All numbers in Millions USD

Apr 2024
Jul 2024
Oct 2024
Jan 2025
Apr 2025
Jul 2025
Oct 2025
Jan 2026
Apr 2026
Jul 2026
Net Income
0
0
-1
0
-1
-2
-1
-2
-2
-3
Operating Cash Flow
-1
-1
-3
-1
0
-2
-1
-1
-2
-1
Investing Cash Flow
-
0
-
-
0
-
-
-
-
-
Financing Cash Flow
1
1
6
0
1
4
-
-
0
8
Change in Cash
0
0
2
0
0
1
-1
-1
-2
6

Alzamend Neuro Annual Cash Flow

All numbers in Millions USD

Apr 2017
Apr 2018
Apr 2019
Apr 2020
Apr 2021
Apr 2022
Apr 2023
Apr 2024
Apr 2025
Apr 2026
Net Income
-1
0
-4
-4
-5
-12
-14
-9
-4
-8
Operating Cash Flow
-1
-2
-1
-2
-2
-6
-8
-8
-6
-8
Investing Cash Flow
-
0
0
0
0
0
-
0
0
-
Financing Cash Flow
1
2
0
2
4
18
0
3
10
4
Change in Cash
0
0
0
0
1
12
-8
-4
3
-3

Global Institutional Holdings in Alzamend Neuro

Check out the Institutions with significant holdings in Alzamend Neuro.

Funds
Holdings
Fidelity Concord Street Trust
0.55%
Vanguard
0.16%
Victory Portfolios III
0.11%
VANGUARD INDEX FUNDS
0.09%

Insights on Alzamend Neuro

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Moderna, Inc. Common Stock has given 152.5% return, outperforming this stock by 252.0%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 738.2% return, outperforming this stock by 779.6%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 3 years, ALZN stock has moved down by -99.5%

About Alzamend Neuro

Alzamend Neuro, Inc., a clinical-stage biopharmaceutical company, focuses on developing various products for the treatment of neurodegenerative and psychiatric disorders. Its pipeline includes AL001, which delivers a therapeutic combination of lithium, proline, and salicylate for the treatment of Alzheimer's, bi-polar disorder, post-traumatic stress disorder, major depressive disorder, other neurodegenerative diseases, and psychiatric disorders; and ALZN002, which uses a method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine to restore the ability of a patient's immunological system to combat Alzheimer's disease. Alzamend Neuro, Inc. was incorporated in 2016 and is headquartered in Atlanta, Georgia.
OrganisationAlzamend Neuro
Headquarters3480 Peachtree Road NE, Atlanta, GA, 30326, US
IndustryBiotechnology
CEOStephan Jackman

Key Management of Alzamend Neuro

Name

Title

Mr. Stephan Jackman

CEO & Director

Mr. Milton Charles Ault III

Founder & Vice Chairman

Mr. David J. Katzoff

Chief Financial Officer

Mr. Henry C. W. Nisser Esq.

Executive VP, General Counsel & Director

Mr. Kenneth S. Cragun CPA

Senior Vice President of Finance

FAQs

What is Alzamend Neuro share price today?

Alzamend Neuro share price today is $1.30 as on at the close of the market. Alzamend Neuro share today touched a day high of $1.34 and a low of $1.25.

What is the 52 week high and 52 week low for Alzamend Neuro share?

Alzamend Neuro share touched a 52 week high of $2.68 on and a 52 week low of $0.84 on . Alzamend Neuro stock price today i.e. is closed at $1.30,which is 51.49% down from its 52 week high and 54.76% up from its 52 week low.

What is Alzamend Neuro's market capitalisation today?

Alzamend Neuro market capitalisation is $0.00T as on .

How to invest in Alzamend Neuro Stock (ALZN) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Alzamend Neuro on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Alzamend Neuro Stock (ALZN) from India?

Indian investors can start investing in Alzamend Neuro (ALZN) shares with as little as ₹94.95999908447266 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹949.60 in Alzamend Neuro stock (as per the Rupee-Dollar exchange rate as on ). Based on Alzamend Neuro share’s latest price of $1.30 as on October 17, 2026 at 8:46 am IST, you will get 7.6923 shares of Alzamend Neuro. Learn more about fractional shares .

What are the returns that Alzamend Neuro has given to Indian investors in the last 5 years?

Alzamend Neuro stock has given -99.96% share price returns and 26.52% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?